Natco Pharma Ltd.

BSE: 532540 NSE: Natco Pharma ISIN:  INE467B01029 SECTOR: IT Software Company Company’s Website: IPO Date & Price: July 29, 2004 | Rs.

Natco Pharma Overview:

Stock Symbol in NSEStock Symbol in BSECurrent PriceMarket Cap. (Cr)P/E RatioCurrent EPS
NSE:NATCOPHARMBSE: 524816₹899.85₹16,412.07₹34.11₹26.38
52 Week High52 Week LowDay OpenDay HighDay LowVolumes
₹996.00₹555.10₹921.85₹921.85₹895.40₹256,210.00
Current Price Fall From 52W high How Near from 52Week Low?Today ChangesNatco Pharma Ltd.Outstanding Shares [Cr.]Face valueLast Traded Time
9.65%38.31%-22.3518.23₹1.004/19/2021 15:30:01
About

Natco Pharma

Its the Indian No-1 multinational information service and consulting Provider company. Natco Pharma is the Subsidiary Company of TATA Group and it’s founded in 1968.

Natco Pharma Sector Performance and Peer Comparison with Sector Analysis:

Did You Know?

<Space for Feature Image>

  • Natco Pharma is the
  • Its Belong to Group.

Balance Sheets & Profit & Loss Account:

YearMar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
Net Profit4449546072103135157486696644461
EPS in Rs.3.143.463.83.834.586.218.19.0227.8837.7435.2425.31
Dividend Payout %8%12%11%16%17%16%12%14%24%22%18%27%
Dividend0.250.420.420.610.780.990.971.266.698.306.346.83
Profit Grouth Rates11.36%10.20%11.11%20.00%43.06%31.07%16.30%209.55%43.21%-7.47%-28.42%
Avearge Profit Grouth Rates10.78%10.89%13.17%19.15%21.13%20.44%44.08%43.98%38.84%32.73%

Natco Pharma Share Price Forecast Based on Current Growth +5/-5:

Share Price and EPS Forecast Based on Current Average Growth Rates:

Next 5 Years (CG)Next 10 Years (CG)Next 20 Years (CG)
₹1,898.74₹7,820.40₹132,665.22
₹104.25₹429.36₹7,283.64
₹2,084.90₹8,587.17₹145,672.74
₹2,606.13₹10,733.97₹182,090.92
₹3,127.36₹12,880.76₹218,509.11
₹3,648.58₹15,027.55₹254,927.29

Share Price and EPS Forecast Based on Current Average Growth Rates Plus 5%:

Next 20 Years (CG+5%)Next 10 Years (CG+5%)Next 5 Years (CG+5%)
₹277,944.42₹11,319.56₹2,284.36
₹7,283.64₹621.47₹125.42
₹145,672.74₹12,429.41₹2,508.34
₹182,090.92₹15,536.77₹3,135.42
₹218,509.11₹18,644.12₹3,762.51
₹254,927.29₹21,751.47₹4,389.59

Share Price and EPS Forecast Based on Current Average Growth Rates Minus 5%:

81100″]

Natco Pharma Quarterly Result, Date & Street Estimate:

Share NameQuarter ResultsYearStreet EstimatesProfitsGrowth
Natco Pharma Ltd.Q1 Results2021
Natco Pharma Ltd.Q2 Results2021
Natco Pharma Ltd.Q3 Results2021
Natco Pharma Ltd.Q4 Results2021
Natco Pharma Ltd.Q1 Results2020
Natco Pharma Ltd.Q2 Results2020
Natco Pharma Ltd.Q3 Results2020
Natco Pharma Ltd.Q4 Results2020

Fundamental Analysis of Natco Pharma :

Natco Pharma Share Long Term Investment Price Target:

Long Term Investment TagetsPriceQnt.Ratio
Lot-1₹697.2020 [1X]
Lot-2₹647.4040 [2X]
Lot-3₹597.6080 [4X]
Lot-4₹547.80180 [8X]

Natco Pharma Fundamentals SWAT Analysis by AMT

 Strengths, Weaknesses, Opportunities, and Threats of Natco Pharma

S

  • Strengths Analysis will coming Soon.

W

  • Weakness Analysis will coming Soon.

O

  • Opportunity Analysis will coming Soon.

T

  • Threats Analysis will coming Soon.

Where we can See Natco Pharma in Next 5 Year, 10 Year & 20 Year?

Technical Analysis of Natco Pharma :

Natco Pharma Share Weekly Swing Trading Price Target:

Demand And Supply ZoneSupport LevelsSupport PriceResistance LevelsResistance Price
250S-1250R-1N/A
226S-2226R-2N/A
217S-3217R-3N/A
202S-4202R-4N/A
191S-5191R-5N/A
183S-6183R-6N/A
166S-7166R-7N/A
158S-8158R-8N/A
141S-9141R-9N/A
S-100R-10N/A
S-110R-11N/A
S-120R-12N/A
S-130R-13N/A
S-140R-14N/A
S-150R-15N/A

Natco Pharma Share Today Intraday Price Target:

IntradayTarget Today [Short Selling]IntradayTarget Today [Long Buying]
₹977.16₹866.54
₹989.15₹861.01
N/AN/A
N/AN/A

FAQ on Natco Pharma :

Is it Good to Buy Natco Pharma Share?

Yes, Natco Pharma is India Number-1 IT Software company, with lots business potential in next few year. Its Fundamentally strong Stock we recommend to buy at around 20-25 PE Ration price target. Anyway This company is quite famous for Good Dividends.

Is Natco Pharma Debt Free Company?

Natco Pharma is a Debt free company. Its can easily survived any down turn for 5-10 Quarter business growth.

Is Natco Pharma Overvalued?

Currently Natco Pharma is Trading at P/E Ratio which is

Is Natco Pharma Better than Infosys?

Both and working as a

Why Natco Pharma Share Price is Falling?

Do to Covid-19 pandemic Natco Pharma Share drastically fall.

Why Natco Pharma Share Price is Going Up?

Is Natco Pharma Good for Long Term Investment?

Its depend on when you and at what price you have buy this share, Natco Pharma at 20-25 P/E Ration is a excellent buy call for long Term Investment.

Natco Pharma ‘s Products/Projects:

Products/ProjectsDescription/Valuation
A.
B.
C.

IPO, Split, Bonus, Dividend Buyback History:

Natco Pharma First IPO was initiate on July 29, 2004. equity shares were put on sale during the IPO with a price band of Rs -Rs per equity share.

[ninja_tables id=”81105″

Company Profile:

CEO NameRajeev Nannapaneni
CFO NameBhaskara Narayana Punyamurthula
CEO Salary ₹ 4.3 Lakhs to ₹ 7.5 Lakhs.
Company AddressMirza, Parlli Part, Assam 781122
Contact Number080743 65626 +91-40-2354 7532
Email Address[email protected]

Declaration: Investing in the Stock market is full of Risky. AllMoneyTips.COM doesn’t give any guarantee or warranted on its investment advice. Do your research before investing in the stock market. Our Forecast and buying selling levels of stocks is based on price action and demand and supply zone. There is no guarantee come with our prediction. Take it as advice only. We are not responsible for your losses on your investments.